Fintel reports that on December 11, 2024, Wells Fargo initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile ...

Your digestive system does more than just process food—it’s home to trillions of tiny organisms, mostly bacteria, that play a ...

In the largest study of its kind in the UK, a research team from Queen’s University Belfast have discovered a new way to ...

Following the previously announced successful End of Phase 2 Meeting achieving agreement with FDA on non-clinical and clinical Phase 3-readiness, Acurx has now also received written positive feedback ...

which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical ...

The gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.1% during the third quarter, according to ...

An analysis of patients with suspected sepsis at US hospitals found that antibiotic de-escalation was infrequent and varied ...